Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

for   crawled time : 13:01    save search

Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 0.36% C: -0.63%
RIGL | $1.135 0.44% 0.44% 520K twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 6.55% C: 6.55%

covid phase 2 trial enroll
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
OPGN | $0.598 -5.18% 50K twitter stocktwits trandingview |
Commercial Services
| | O: 1.35% H: 11.68% C: 4.83%

financial results results
Nuvation Bio Granted Orphan Drug Designation for NUV-422 for the Treatment of Patients with Malignant Gliomas
Published: 2021-03-11 (Crawled : 13:01) - biospace.com/
NUVB | $2.68 0.0% 880K twitter stocktwits trandingview |
| | O: 1.86% H: 7.83% C: 5.32%

treatment drug granted grant designation
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2020
Published: 2021-03-09 (Crawled : 13:01) - globenewswire.com
SURF | $1.07 -0.93% -1.41% 0 twitter stocktwits trandingview |
Health Technology
| | O: 14.95% H: 2.36% C: -2.25%

financial results results
Gilat's In-Flight Connectivity High-Power Transceiver Successfully Tested by Global Eagle Entertainment for DO-160G Certification
Published: 2021-03-03 (Crawled : 13:01) - globenewswire.com
GILT | $5.35 0.75% 0.75% 72K twitter stocktwits trandingview |
Electronic Technology
| | O: 0.93% H: 0.06% C: -10.86%

test
Vislink Awarded $4 Million U.S. Department of Defense Order for Handheld Intelligence, Surveillance and Reconnaissance (ISR) Receiver Devices and Accessories
Published: 2021-03-02 (Crawled : 13:01) - globenewswire.com
VISL | $4.08 1.58% 1.56% 7.5K twitter stocktwits trandingview |
Electronic Technology
| | O: 16.87% H: 6.19% C: 2.58%

defense device order
Clearside Biomedical Announces Completion of Patient Dosing in First Cohort of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
Published: 2021-03-02 (Crawled : 13:01) - globenewswire.com
CLSD | News P | $1.36 -3.55% -3.68% 230K twitter stocktwits trandingview |
Health Technology
| | O: 3.48% H: 0.28% C: -4.48%

treatment phase 1 trial phase 3 phase 2 axitinib cls-ax dmd injection
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
Published: 2021-03-02 (Crawled : 13:01) - globenewswire.com
MYGN | $18.595 0.57% 0.56% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.3% C: -7.91%

offering genetic test genomic
OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
Published: 2021-03-01 (Crawled : 13:01) - globenewswire.com
OPGN | $0.598 -5.18% 50K twitter stocktwits trandingview |
Commercial Services
| | O: 8.73% H: 1.61% C: -12.05%

chinese approval system
Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X-Ray Source
Published: 2021-02-23 (Crawled : 13:01) - globenewswire.com
SRTS | $3.41 0.59% 0.59% 71K twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 5.41% C: 3.09%

patent granted grant
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Published: 2021-02-23 (Crawled : 13:01) - globenewswire.com
ADPT | $2.575 2.59% 2.52% 1.5M twitter stocktwits trandingview |
Commercial Services
| | O: -1.27% H: 2.57% C: 1.36%

covid test biotech iot t-cell injection infections
Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance
Published: 2021-02-22 (Crawled : 13:01) - globenewswire.com
BNGO | $0.7928 4.23% 4.06% 820K twitter stocktwits trandingview |
Health Technology
| | O: -5.9% H: 4.78% C: -7.2%

disease
New VPN Risk Report by Zscaler Uncovers Hidden Security Risks Impacting Enterprises and Offers Alternatives for Secure Remote Access
Published: 2021-02-16 (Crawled : 13:01) - globenewswire.com
ZS | $176.93 3.49% 3.37% 2.2M twitter stocktwits trandingview |
Technology Services
| | O: 1.94% H: 0.0% C: -3.14%

security risk
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study
Published: 2021-02-04 (Crawled : 13:01) - globenewswire.com
CRNX G | $44.21 1.77% 1.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 2.72% H: 4.71% C: 0.9%

renal disease phase 3 phase 1 phase 2
Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance
Published: 2021-02-02 (Crawled : 13:01) - globenewswire.com
VVOS | $2.64 -1.12% 35K twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 4.42% C: -3.99%

fda application
Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
Published: 2021-02-02 (Crawled : 13:01) - globenewswire.com
MYGN | $18.595 0.57% 0.56% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 4.6% C: 3.0%

genetic rheumatoid arthritis risk cardio cardiovascular
American Medical Association Issues New CPT Code for Neovasc Reducer Procedure
Published: 2021-01-29 (Crawled : 13:01) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.0% C: -4.8%


Metromile Receives the Necessary Regulatory Approvals for Proposed Business Combination with INSU Acquisition Corp. II
Published: 2021-01-29 (Crawled : 13:01) - globenewswire.com
INAQ | $10.86 -0.73% -0.74% 4.7K twitter stocktwits trandingview |
Finance
| | O: -1.34% H: 4.47% C: -0.2%

acquisition acquisition corp approval
Hudbay to Host Conference Call for Fourth Quarter 2020 Results
Published: 2021-01-27 (Crawled : 13:01) - globenewswire.com
HBM | $7.73 0.78% 0.0% 2M twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -3.51% H: 0.17% C: -3.29%

results conference
Regency Centers Issues TCFD Climate Change Risk Report and is Recognized for Corporate Responsibility Leadership
Published: 2021-01-27 (Crawled : 13:01) - globenewswire.com
REG | $60.1 1.5% 1.48% 700K twitter stocktwits trandingview |
Finance
| | O: -1.13% H: 2.57% C: -0.55%

risk response
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.